For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Mesenchymal Stem Cells (MSC), also termed Mesenchymal Stromal Cells, are multipotent cells that can differentiate into a variety of cell types and have the capacity for self-renewal. MSC have been shown to differentiate in vitro or in vivo into adipocytes, chondrocytes, osteoblasts, myocytes, neurons, hepatocytes, and pancreatic islet cells. Optimized PromoCell media are available to support both the growth of MSC and their differentiation into several different lineages. Recent experiments suggest that differentiation capabilities into diverse cell types vary between MSC of different origin.
Scope of the Report:
In the last several years, Global market of Mesenchymal Stem Cells developed rapidly, with an average growth rate of 6.2%. In 2015, Global revenue of Mesenchymal Stem Cells is about 110 M USD.
The global average gross margin of Mesenchymal Stem Cells is in the fluctuation trend, from 70% in 2012 to 67% in 2016. With the situation of global economy, gross margin will be in decreasing trend in the following five years.
The type of Mesenchymal Stem Cells includes Human, Mouse, Rat. The proportion of Human in 2015 is about 39%, and the proportion of Mouse in 2016 is about 31%.
The global Mesenchymal Stem Cells market is valued at 170 million USD in 2018 and is expected to reach 220 million USD by the end of 2024, growing at a CAGR of 4.3% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Mesenchymal Stem Cells.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Mesenchymal Stem Cells market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Mesenchymal Stem Cells market by product type and applications/end industries.
Market Segment by Companies, this report covers
- Thermo Fisher
- PromoCell GmbH
- Cell Applications
- Cyagen Biosciences
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Human MSC
- Mouse MSC
- Rat MSC
Market Segment by Applications, can be divided into
- Research Institute